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Abstract
Hereditary thoracic aortic diseases (HTAD) such as Marfan syndrome (MFS) affect 
multiple organ systems and provide a risk of acute aortic dissection, which causes 
lifelong uncertainties. Although health-related quality of life (HRQOL) was found to 
be reduced in HTAD patients, no studies have evaluated male–female-specific as-
pects of HRQOL and coping in this population. This study aims to evaluate HRQOL in 
HTAD patients compared to the general population; assess male–female differences 
in HRQOL and factors associated with HRQOL; evaluate coping styles in male and 
female HTAD patients and identify factors associated with acceptance. All consecu-
tive adult patients who visited the specialized HTAD outpatient clinic between 2013 
and 2018 were asked to complete three HRQOL questionnaires: the Short Form 
36 (SF-36), the Hospital Anxiety and Depression Scale (HADS), and the Nijmegen 
Clinical Screening Instrument (NCSI). In total, 142 patients were included (mean age 
42.1 years, 65 females, 123 MFS). Compared to the general population, HTAD patients 
scored significantly lower on multiple SF-36 sub-domains (males: General Health 
54.5 ± 18.8 vs. 71.6 ± 20.6, p < .001; Vitality 58.3 ± 20.4 vs. 71.9 ± 18.3, p < .001; 
females: Physical Functioning 67.5 ± 23.8 vs. 80.4 ± 24.2, p = .003; Role Physical 
58.3 ± 45.1 vs. 73.8 ± 38.5, p = .047; General Health 49.4 ± 24.3 vs. 69.9 ± 20.6, 
p < .001; Social Functioning 73.5 ± 22.0 vs. 82.0 ± 23.5, p = .027). Females scored 
significantly lower than males on the SF-36 physical component score (41.6 [IQR 
35.5–53.1] vs. 49.3 [IQR 42.3–54.6], p = .035). Males scored significantly higher on 
the coping style denial than females (2.75 [IQR 2.00–3.25] vs. 2.25 [IQR 1.75–3.25], 
p = .018). High scores on acceptance were found in 38 (26.8%) of HTAD patients, and 
these patients showed significantly better scores on the NCSI, SF-36, and HADS, ex-
cept on NCSI Satisfaction Relationships and SF-36 Physical Functioning and Mental 
Health. Acceptance was associated with more medication use (beta blocker use, 
p = .008; angiotensin receptor blocker use, p = .003) and less hypertension (p = .001). 
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1  | INTRODUC TION
The incidence of thoracic aortic diseases including thoracic aortic an-
eurysms and dissections has been increasing and is currently estimated 
to be about 9 per 100,000 per year in women, and 16 per 100,000 per 
year in men (Olsson, Thelin, Stahle, Ekbom, & Granath, 2006). In over 
20 percent of cases, there is an inherited pattern for thoracic aortic 
aneurysms (Albornoz et al., 2006), and often multiple family members 
are affected. Patients with these hereditary thoracic aortic diseases 
(HTAD), such as Marfan syndrome (MFS), often experience multiple 
serious complaints during their lifetime, which are mostly due to skel-
etal, ocular, or cardiovascular manifestations. On top of that, these pa-
tients are at risk of acute aortic dissection (Murdoch, Walker, Halpern, 
Kuzma, & McKusick, 1972). Therefore, HTAD patients with or without 
aortic involvement face many uncertainties and require lifetime med-
ical surveillance, lifestyle alterations, pharmaceutical treatment, and 
often surgical procedures.
Evidence of the effects of living with this potentially life-threatening 
inheritable disease on health-related quality of life (HRQOL) is scarce. 
So far, it has been shown that HTAD patients have a lower HRQOL 
compared to the general population and comparable to other chronic 
diseases (Goldfinger et al., 2017; Olsson & Franco-Cereceda, 2013). 
Physical aspects seem affected rather than mental well-being (Olsson 
& Franco-Cereceda, 2013; Rand-Hendriksen et al., 2010). Moon et al. 
showed that apart from disease-related factors, there are other import-
ant factors which influence HRQOL in MFS patients, such as social sup-
port (e.g. family/friends support) and bio-behavioral factors (e.g. anxiety, 
depression, fatigue, pain; Moon, Cho, Huh, Kang, & Kim, 2016). Even 
though evidence on HRQOL in HTAD patients, and MFS patients in par-
ticular, is gradually increasing, guidelines on current clinical practice do 
not yet include any HRQOL assessment, psychosocial assessment, or 
psychological counseling (Erbel et al., 2014; Hiratzka et al., 2010).
Better insight into HRQOL in HTAD patients could help guide 
genetic counseling, help to explain the relevance of HRQOL to our 
patients, and aid the creation of intervention strategies for improv-
ing HRQOL in this population. In particular, it is important to know in 
which specific subgroups of HTAD patients HRQOL is most impaired, 
in order to increase clinician awareness of HRQOL impairment 
and coping problems in these patients. However, patient-specific 
evidence is lacking. Even though HRQOL is known to be different in 
men and women both in the general population and in specific pa-
tient groups (Angst et al., 2002; Norris et al., 2008), no studies have 
evaluated male–female-specific aspects of HRQOL in this popula-
tion. Furthermore, very little is known about coping strategies and 
disease acceptance in HTAD patients, while the latter is known to 
be an important patient-related factor contributing to patients’ ad-
herence to long-term treatments (Connors, Jeremy, Fisher, Sharpe, 
& Juraskova, 2015; Jankowska-Polanska, Blicharska, Uchmanowicz, 
& Morisky, 2016). Therefore this study aims to (a) Evaluate male–
female-specific HRQOL in HTAD patients compared to the general 
population, (b) Assess male–female differences in HRQOL and iden-
tify male–female-specific factors associated with HRQOL, and (c) 
Evaluate coping styles in male and female HTAD patients and iden-
tify factors associated with the coping style acceptance.
2  | METHODS
2.1 | Participants
All consecutive adult patients (≥18 years old) who visited the spe-
cialized HTAD outpatient clinic at the Radboud University Medical 
Center in Nijmegen between 2013 and 2018 were asked to fill-out 
three quality of life questionnaires: the Short Form 36 (SF-36), the 
Hospital Anxiety and Depression Scale (HADS), and the Nijmegen 
Clinical Screening Instrument (NCSI). The HTAD outpatient clinic 
is a multidisciplinary clinic in which patients are seen by cardiolo-
gists, nurse practitioners, or clinical geneticists over the course of 
annual visits. Questionnaires were distributed directly after an out-
patient clinic visit, which was a cardiovascular follow-up visit with 
their cardiologist or nurse specialist. If patients completed the ques-
tionnaires multiple times, only the first measurements were used, 
in order to avoid bias created by counseling sessions at the HTAD 
outpatient clinic. Exclusion criteria were related to inability to com-
plete the online surveys, such as a language barrier, intellectual dis-
ability, no access to a computer or email address, or unwillingness 
to complete the questionnaires. The questionnaires were primarily 
used in clinical practice for patients visiting the HTAD outpatient 
In patients with MFS, employment was strongly associated with better scores on the 
NCSI. In conclusion, HTAD patients showed subnormal HRQOL, especially females. 
Interestingly, in both males and females factors such as employment, coping style, 
and disease acceptance seem more important for HRQOL than disease-related fac-
tors. This highlights the importance of genetic counseling and guidance for HTAD 
patients, and offers valuable leads for HRQOL improvement.
K E Y W O R D S
distress, genetic counseling, health-related quality of life, Marfan syndrome, mental health, 
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     |  3THIJSSEN ET al.
clinic of our tertiary care center, in order to assess overall mental 
and physical health status and to develop patient-specific treat-
ment goals for counseling if necessary. Additional data were col-
lected from the patient files using a standardized case report form 
shown in Supporting Information S1. Only information collected 
within 3 months from the date of completion of the questionnaires 
was used. Diagnosis of MFS was defined as fulfillment of the criteria 
of the revised Ghent nosology (Loeys et al., 2010). This study was 
approved by the local ethics committee (ethics committee of the 
Radboud University Nijmegen Medical Centre, file number: 2019–
5451) and was designed, performed, and controlled in accordance 
with current local and international good clinical practice guidelines 
(De Nederlandse Gedragscode Wetenschapsbeoefening, 2014; The 
European Code of Conduct for Research Integrity Revised Edition, 
2017; WMA Declaration of Helsinki – Ethical Principles for Medical 
Research Involving Human Subjects, 2013).
2.2 | Questionnaires
The SF-36 questionnaire is a widely used HRQOL questionnaire with 
36 items, which comprises eight domains: Physical Functioning (PF), 
Role limitations due to Physical health problems (RP), Bodily Pain (BP), 
General Health perceptions (GH), Vitality (VT), Social Functioning (SF), 
Role limitations due to Emotional problems (RE), and general Mental 
Health (psychological distress; MH; Aaronson et al., 1998; Ware Jr. & 
Sherbourne, 1992). The first four domains (PF, RP, BP & GH) comprise 
the Physical Component Summary (PCS), and the last four domains 
(VT, SF, RE & MH) comprise the Mental Component Summary (MCS). 
All SF-36 sub-domains have a score range of 0–100, with higher 
scores reflecting a better quality of life. The SF-36 has been trans-
lated and validated in the Dutch language, and norm scores of the 
general Dutch population are available (Aaronson et al., 1998). Male 
and female scores of HTAD patients on the eight sub-domains of the 
SF-36 were compared to male–female-specific norm values (Aaronson 
et al., 1998). Unfortunately, no age-specific norm values are available 
for males and females separately; additional age-matching was there-
fore not possible (Aaronson et al., 1998). Male–female-specific PCS 
and MCS scores were calculated using the mean and standard devia-
tions from the general Dutch population. SF-36 scores of patients who 
previously underwent aortic surgery were compared to patients who 
had not undergone aortic surgery, and patients who experienced pre-
vious aortic dissection were compared to those who did not.
The HADS is a commonly used questionnaire to assess signs 
of anxiety and depression. This 14-item scale is divided in two di-
mensions: anxiety (seven items) and depression (seven items). The 
responses result in a score for each dimension with a score range 
of 0–21 and a total overall score range of 0–42. Higher scores rep-
resent higher levels of anxiety and depression. The HADS was val-
idated in the Dutch language (Spinhoven et al., 1997). A score of 
8+ on the HADS anxiety and depression subscales was defined as 
elevated, since this cutoff point was found to be the most optimal 
(Bjelland, Dahl, Haug, & Neckelmann, 2002).
The NCSI contains 49 questions and was designed to assess 
the overall health status of patients, identifying patient-specific 
treatment goals in order to facilitate behavioral changes (Peters 
et al., 2009). The NCSI has eight sub-domains: General Quality Of 
Life; Health-Related Quality of Life; Satisfaction with Relationships; 
Subjective Impairments; Behavioral Impairments; Subjective 
Symptoms; Emotions about Symptoms; and Fatigue. Each of the 
eight sub-domains has its own specific score range as shown in 
Table 3, with higher scores reflecting more problems on the sub-do-
main. Therefore, lower scores on the NCSI sub-domains reflect a 
better quality of life. Additionally, the NCSI includes the ADIQ ques-
tionnaire as a measure of coping style, which is based on the stages 
of grief by Kübler-Ross (1970), which shows resemblances with the 
stages of disease acceptance: denial, resistance, sorrow, and accep-
tance. For assessment of each stage, there are three to four ques-
tions (Boer et al., 2014). Scores on every stage are transformed to a 
score range of 1–4, with higher scores reflecting better agreement 
of this stage with the coping style used by the patient. High scores 
on the ADIQ stages were defined as a score of 3+. Scores on the 
ADIQ were compared between males and females for each coping 
style. Both the NCSI and ADIQ were originally designed and vali-
dated in patients with chronic obstructive pulmonary disease (Boer 
et al., 2014; Peters et al., 2009), and were used thereafter in pa-
tients with Q-fever and asthma (Peters et al., 2014; van Loenhout 
et al., 2013). Unfortunately, norm scores for the general Dutch pop-
ulation are not available; therefore, the NCSI could not be used to 
compare HTAD patients to the general population.
2.3 | Data analysis
Data were analyzed using SPSS statistics (IBM SPSS Statistics ver-
sion 25). Continuous data were presented as mean and standard 
deviation (SD) when normally distributed, and as median with inter-
quartile range (IQR) when skewed. Categorical data were presented 
as frequencies with percentages. Students t test or non-parametric 
Wilcoxon test were used to compare continuous variables, and chi-
squared test was used to compare categorical variables. The one-
sample student's t test was used to compare SF-36 norm values to 
the study population means. For the patients with MFS, baseline 
variables that showed a significant association with scores on one of 
the NCSI sub-domains (p < .05) in univariate analysis were included 
in a multifactor analysis of variance to identify those strongly associ-
ated with scores on this sub-domain. A p-value of <.05 was consid-
ered significant.
3  | RESULTS
In total, 142 HTAD patients (65 females) completed one or more 
questionnaires. All 142 patients completed the NCSI question-
naire, 76 patients (36 females) subsequently completed the SF-36 
questionnaire, and 113 patients (49 females) completed the HADS. 
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Baseline characteristics (shown in Table 1) were compared between 
males and females; patients who completed the SF-36 and those 
who did not; and patients who completed the HADS and those who 
did not. Males had a significantly larger aortic root diameter com-
pared to females (p = .001), although the aortic root Z-scores were 
not significantly different (p = .635). Patients who completed the 
SF-36 had a significantly larger aortic root diameter (41.5 ± 5.3 mm 
vs. 38.6 ± 5.3 mm, p = .006), and aortic root Z-score (3.2 [IQR 1.9–4.8] 
vs. 2.2 [IQR 1.2–3.5], p = .004) than those who did not. Patients who 
completed the HADS questionnaire had significantly larger aortic di-
ameters than those who did not (40.7 ± 5.4 mm vs. 38.2 ± 5.6 mm, 
p = .042). However, the aortic root Z-score was not significantly dif-
ferent (p = .135). There was no significant difference between the 
percentage of males and females who completed the SF-36 (52.6% 
vs. 47.4%, p = .682) and the HADS (56.6% vs. 43.4%, p = .255). A large 
proportion of our cohort (123/142 patients) was diagnosed with 
MFS. Therefore, we additionally compared patients with diagnosis of 
MFS to patients without MFS, as is shown in Supporting Information 
S2. Patients with MFS were significantly younger (41.0 ± 14.3 vs. 
49.2 ± 16.3, p = .023). The remaining patients were diagnosed with 
Loeys–Dietz syndrome (n = 8), ACTA2 mutation (n = 1), and other 
genetic mutations (n = 5), or had no established genetic mutation 
but did have a thoracic aortic aneurysm and positive family history 
of aortic disease.
3.1 | HRQOL in HTAD patients
Table 2 shows the SF-36 scores of male and female HTAD patients 
compared to male and female norm scores of the general Dutch pop-
ulation (Aaronson et al., 1998). Overall, male and female HTAD pa-
tients both showed lower scores than the general population on most 
Total (n = 142) Males (n = 77) Females (n = 65) p-value
Age – years 42.1 ± 14.8 42.1 ± 14.9 42.1 ± 14.8 .977
BMI – kg/m2 23.5 ± 4.5 24.2 ± 4.7 22.7 ± 4.2 .059
Hypertension 17 (12.0) 9 (11.7) 8 (12.3) .910
Hyperlipidemia 16 (11.3) 11 (14.3) 5 (7.7) .216
Current smoker 17 (12.9) 8 (11.0) 9 (15.3) .464
Renal dysfunction 2 (1.8) 0 (0) 2 (4.2) .097
Beta blocker use 92 (64.8) 55 (71.4) 37 (56.9) .071
ARB use 59 (41.5) 34 (44.2) 25 (38.5) .493
Aortic root diameter 
- mm
40.1 ± 5.5 41.8 ± 5.0 38.4 ± 5.5 .001
Z-score 2.7 ± 2.0 2.6 ± 2.0 2.8 ± 2.1 .635
Abdominal aortic 
aneurysm
18 (12.9) 12 (16.0) 6 (9.4) .246
Normal LVEF 135 (96.4) 72 (94.7) 63 (98.4) .240
Previous surgery 46 (32.4) 28 (36.4) 18 (27.7) .271
Previous dissection 21 (14.8) 13 (16.9) 8 (12.3) .444
Diagnosis .317
Marfan syndrome 123 (86.6) 66 (85.7) 57 (87.7)
Loeys–Dietz 
syndrome
8 (5.6) 4 (5.2) 4 (6.2)
ACTA2 mutation 1 (0.7) 0 (0.0) 1 (1.5)
Other 5 (3.5) 2 (2.6) 3 (4.6)
None 5 (3.5) 5 (6.5) 0 (0.0) .730
Positive systemic 
score > 7
41 (28.9) 25 (32.5) 16 (24.6) .304
Positive family history 
MFS
80 (62.5) 44 (65.7) 36 (59.0) .437
Current partner 85 (68.5) 48 (71.6) 37 (64.9) .421
Current worka  88 (66.2) 42 (72.4) 27 (62.8) .304
Note: Data are expressed as M ± SD or as absolute and percentage.
Abbreviations: HTAD, hereditary thoracic aortic disease; BMI, body mass index; ARB, angiotensin II 
receptor blocker; LVEF, left ventricular ejection fraction; MFS, Marfan syndrome.
aOnly working age (25–65 years) n = 107. 
TA B L E  1   Baseline characteristics
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SF-36 sub-domains. In females, however, scores were significantly 
lower in HTAD patients compared to the general population for: 
Physical Functioning (67.5 ± 23.8 vs. 80.4 ± 24.2, p = .003), General 
Health (49.4 ± 24.3 vs. 69.9 ± 20.6, p < .001, Social Functioning 
(73.5 ± 22.0 vs. 82.0 ± 23.5, p = .027), and Role Physical (58.3 ± 45.1 
vs. 73.8 ± 38.5, p = .047). Males showed significantly lower scores 
compared to the general population for: General Health (54.5 ± 18.8 
vs. 71.6 ± 20.6, p < .001) and Vitality (58.3 ± 20.4 vs. 71.9 ± 18.3, 
p < .001).
3.2 | HRQOL in males versus females
Table 3 shows male–female-specific scores on all sub-domains of the 
three HRQOL questionnaires. On the SF-36 questionnaire, females 
scored lower on most sub-domains, with a significantly lower score on 
Physical Functioning (90.0 [IQR 70.0–95.0] vs. 75.0 [IQR 55.0–83.8], 
p = .005) and on the Physical Component Summary (47.8 ± 9.1 vs. 
43.0 ± 10.6, p = .035) but not on the Mental Component Summary 
(50.5 [IQR 44.4–55.5] vs. 52.4 [IQR 44.5–56.2], p = .411). On the 
HADS questionnaire no significant differences were seen between 
sub-scores of males and females. Of females, 18/49 (36.7%) demon-
strated elevated scores on the HADS anxiety sub-domain versus 18/64 
(28.1%) of males (p = .330). On depression 9/49 (18.4%) of females 
showed elevated scores versus 14/64 (21.9%) of males (p = .646). On 
the NCSI females scored significantly higher than males on the sub-
domain Behavioral Impairments (8.8 [IQR 0.0–19.3] vs. 0.0 [IQR 0.0–
11.0], p = .013), reflecting a lower quality of life on this sub-domain.
Additionally, HTAD patients rated their overall quality of life on a 
0–10 scale; the mean rate in both males and females was 7.3.
3.3 | Previous aortic complications
SF-36 scores of patients, who previously underwent aortic surgery 
(22/76) or had an aortic dissection (10/76), were compared to patients 
who did not. Patients who did have surgery showed significantly 
less favorable scores on the sub-domain Physical Functioning on 
the SF-36 (64.1 ± 25.4 vs. 79.2 ± 19.4, p = .014) compared to pa-
tients with no prior surgery. Additionally, they showed less favorable 
(=higher) scores on the sub-domain Behavioral Impairments on the 
NCSI (13.4 ± 16.0 vs. 8.7 ± 13.9, p = .039). Patients with previous 
aortic dissection showed less favorable scores on the SF-36 sub-
domains Physical Functioning (57.5 ± 21.4 vs. 77.4 ± 21.3, p = .006), 
Social Functioning (62.8 ± 18.8 vs. 78.6 ± 22.1, p = .019), and Bodily 
Pain (62.8 ± 18.8 vs. 78.6 ± 22.1, p = .019).
3.4 | Coping styles
Male and female scores on the ADIQ were compared for the use 
of different coping styles. Males scored significantly higher on the 
coping style denial than females (2.75 [IQR 2.00–3.25] vs. 2.25 [IQR 
1.75–3.25], p = .018). High scores on the subscale disease accept-
ance were present in 38 (49.4%) of males and 23 (35.4%) of females 
(p = .094). However, a false view of acceptance might be presented if 
patients who have high denial as well as high acceptance are included 
in this analysis. Therefore, we additionally performed analyses for 
patients with ‘true acceptance’, who showed a high score on the cop-
ing style acceptance without a high score on denial. This led to a true 
acceptance rate of 22 (28.6%) in males and 16 (24.6%) in females 
(p = .596). Table 4 shows differences in scores on all sub-domains 
of the three HRQOL questionnaires between patients with high 
acceptance or true acceptance, and patients without. Differences 
in baseline characteristics between patients with and without true 
acceptance were assessed. Patients with true acceptance were sig-
nificantly younger (38.1 ± 15.1 vs. 43.5 ± 14.5, p = .044), used beta 
blockers significantly more often (78.9% vs. 59.6%, p = .033), and 
significantly more often had a genetically confirmed FBN1 mutation 
(97.3% vs. 83.2%, p = .029). Multivariate analysis showed significant 
associations between acceptance and the following baseline char-
acteristics and NCSI sub-domains after correction for sex and age: 
hypertension (p = .001), current beta blocker use (p = .008), and an-
giotensin receptor blocker (ARB) use (p = .003).
TA B L E  2   SF-36 scores: comparison of HTAD males and females to the general population
SF-36 subdomain
Males HTAD 
(n = 40)
Males general 
population p-value
Females HTAD 
(n = 36)
Females general 
population p-value
Physical functioning 81.4 ± 18.7 85.4 ± 21.0 .181 67.5 ± 23.8 80.4 ± 24.2 .003
Role physical 68.1 ± 39.2 78.7 ± 34.1 .096 58.3 ± 45.1 73.8 ± 38.5 .047
Bodily pain 79.1 ± 22.4 77.3 ± 22.7 .609 73.5 ± 22.0 71.9 ± 23.8 .658
General health 54.5 ± 18.8 71.6 ± 20.6 <.001 49.4 ± 24.3 69.9 ± 20.6 <.001
Vitality 58.3 ± 20.4 71.9 ± 18.3 <.001 57.8 ± 21.3 64.3 ± 19.7 .075
Social functioning 79.1 ± 22.4 86.0 ± 21.1 .059 73.5 ± 22.0 82.0 ± 23.5 .027
Role emotional 80.8 ± 36.1 85.5 ± 29.9 .419 81.5 ± 33.3 78.5 ± 35.7 .594
Mental health 74.0 ± 18.2 79.3 ± 16.4 .074 73.6 ± 18.3 73.7 ± 18.2 .963
Data are expressed as M ± SD.
Abbreviations: HTAD, Hereditary Thoracic Aortic Disease; SF-36, Short Form 36 questionnaire.
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3.5 | Baseline characteristics associated with 
HRQOL in MFS patients
HTAD patients who were employed showed significantly lower 
scores (indicating a better quality of life) on seven out of eight NCSI 
sub-domains, compared to HTAD patients who were not employed. 
One sub-domain (General Quality of Life) was borderline significant 
(p = .053). This analysis was done for the whole cohort (all ages), 
but the difference was even more pronounced when only HTAD of 
working age (18–65 years old, n = 129) were included in the analy-
sis. No differences could be found for any of the baseline variables 
between HTAD patients of working age (18–65 years old) with and 
without employment. Except patients with employment had sig-
nificantly less hyperlipidemia than those without (21.6% vs. 4.8%, 
p = .005).
Multivariate analysis showed significant associations with the 
following baseline characteristics and NCSI sub-domains after cor-
rection for sex and age. Employment was associated with more fa-
vorable scores on 5/8 NCSI sub-domains: Health-Related Quality of 
Life; Subjective Impairments; Behavioral Impairments; Subjective 
Symptoms; and Fatigue Symptoms. Hypertension was signifi-
cantly associated with less favorable scores on: General Quality 
of Life; Health-Related Quality of Life; Subjective Impairments 
and Emotions about Symptoms. Larger aortic root diameter was 
significantly associated with less favorable scores on Subjective 
Symptoms. Having a partner was significantly associated with better 
scores on Satisfaction Relationships. Smoking was associated with 
less favorable General Quality of Life score. Sex was not significantly 
associated with scores on any sub-domain of the NCSI.
4  | DISCUSSION
To our knowledge, this is the first study to evaluate male–female-
specific aspects, and male–female differences in HRQOL in HTAD 
patients. Very few studies have previously evaluated coping styles 
in these patients. We found both male and female HTAD patients 
had lower HRQOL compared to the general population. In female 
HTAD patients, physical well-being and behavioral functioning 
seemed most affected. Disease acceptance was comparable in male 
and female HTAD patients, while males scored significantly higher 
on the coping style ‘denial’. Disease acceptance was found to be 
independently associated with medication use and absence of hy-
pertension. Although HRQOL was lower in females, we could not 
identify any factors associated with HRQOL specifically for either 
for males or females that could explain this difference. However, 
employment and disease acceptance were strongly associated with 
better HRQOL in both males and females.
Compared to the general Dutch population, both male and fe-
male HTAD patients scored lower on almost all SF-36 sub-domains. 
These findings are in accordance with the findings of studies in 
HTAD patients and patients with MFS, including children and young 
adults, which equally showed a reduced HRQOL compared to the 
general population (Goldfinger et al., 2017; Handisides et al., 2019; 
Olsson & Franco-Cereceda, 2013; Rand-Hendriksen et al., 2010; 
Schoormans et al., 2012). This in contrast to adults with congenital 
heart disease, who were found to report a better HRQOL than the 
general population (Moons et al., 2006; Opic et al., 2015). Females 
predominantly reported problems on physical rather than mental as-
pect shown by significantly lower scores on 3/4 sub-domains of the 
PCS (Table 2). Remarkably, both male and female HTAD patients did 
not show lower scores on Bodily Pain when compared to the gen-
eral population. This indicates that it might not be pain or discomfort 
causing lower scores on physical well-being, but caused instead by 
physical disabilities.
In our study, females showed more unfavorable scores on all 
three HRQOL questionnaires than males, which was also observed 
in the general Dutch population and other specific patient groups 
(Aaronson et al., 1998). This male–female difference was significant 
for: Behavioral Impairments (NCSI) and Physical Functioning (SF-36). 
These two sub-domains on the NCSI and SF-36 questionnaires have 
been compared previously, and were found to correlate well (R = .71; 
van Loenhout et al., 2013). Moreover, females scored significantly 
lower on the PCS of the SF-36. On the other hand, there was no sig-
nificant difference between males and females for any of the base-
line characteristics, including systemic score of MFS (according to 
the revised Ghent criteria) and previous aortic surgery or dissection 
(Loeys et al., 2010). It seems therefore that females were not more 
physically affected by the disease than males. Potentially this drop 
in self-reported physical well-being can be explained by the physical 
disabilities and limitations that HTAD patients experience in daily 
life, rather than the presence of pain or symptoms themselves.
We found a non-significant slightly higher prevalence of anxi-
ety in females compared to males. A higher prevalence of anxiety 
in females compared to males was also found in the general pop-
ulation (Angst et al., 2002; Bijl, Ravelli, & van Zessen, 1998). In fe-
male HTAD patients, however, prevalence of anxiety seems to be 
markedly higher than in the general Dutch population (36.7% vs. 
19.3%; Bijl et al., 1998). Surprisingly, the HADS outcomes showed 
a non-significant higher prevalence of depression in male HTAD pa-
tients compared to females. This is inconsistent with epidemiolog-
ical studies which demonstrate a higher prevalence of depression 
in females compared to males. Although the prevalence is com-
parable to the general Dutch population where the prevalence of 
mood disorders was reported to be about 19% (Bijl et al., 1998). On 
the other hand, this is much lower than the rate of 44% depression 
previously reported in MFS (Peters, Kong, Horne, Francomano, & 
Biesecker, 2001), although this was measured using a different ques-
tionnaire for assessment of depressive symptoms.
HTAD patients with high scores on disease acceptance showed 
significantly better scores on almost all sub-domains, including lower 
scores on the HADS anxiety and depression subscales, which over-
all represents a better HRQOL. Males showed significantly higher 
scores on denial than females. Denial has been associated with lower 
distress (Carver et al., 1993). Theoretically, this might contribute 
to males showing better scores on HRQOL and less anxiety. Even 
     |  7THIJSSEN ET al.
though males show higher denial, the true acceptance rate cor-
rected for denial was not significantly different between males and 
females. Disease acceptance in our HTAD population was markedly 
lower than the 54%–65% previously reported (Connors et al., 2015; 
Van Tongerloo & De Paepe, 1998). This could be caused by the lack 
of a gold standard for measuring coping styles, which leads to the 
use of different measurement methods. In this study, we have used 
the ADIQ questionnaire, whereas previous studies have used the 
‘Utrechtse Coping Lijst’ and ‘The Coping Orientation to Problems 
Experienced inventory (COPE)’ (Connors et al., 2015; Van Tongerloo 
& De Paepe, 1998). Furthermore, one study used the old Ghent 
Criteria for the diagnosis of MFS for inclusion of patients, and addi-
tionally included much younger patients (mean age 22.6 ± 4.8 years; 
Van Tongerloo & De Paepe, 1998). Moreover, these studies all have 
very small sample sizes, which might contribute to the variation in 
findings. More importantly, disease acceptance is known to be an 
important factor in relation to patients’ adherence to treatment 
(Connors et al., 2015; Jankowska-Polanska et al., 2016). HTAD 
patients are always under long-term surveillance, receive counsel-
ing on lifestyle modifications (e.g. exercise, smoking) and are often 
prescribed medication. Beta blocker and ARB use were found to be 
positively associated with acceptance, and hypertension was nega-
tively associated with acceptance. Furthermore, hypertension was 
associated with less favorable scores on the NCSI, indicating more 
problems and lower HRQOL. This strengthens the assumption that 
disease acceptance improves patients’ adherence to medical treat-
ment, with adherent patients having less hypertension. Our results 
emphasize that coping style, and especially disease acceptance, is 
underexposed, but truly important in the management of HTAD 
patients. These findings correspond with a previous study showing 
that bio-behavioral factors play a big role in quality of life of MFS 
patients (Moon et al., 2016).
Employment seems to be a very important factor in HRQOL of 
patients with MFS. It is striking that the association with such daily 
life aspects seems so strong, whereas medical- and disease-related 
factors such as aortic root diameter, previous surgery, family history, 
TA B L E  3   HTAD male–female 
differences in scores on NCSI, SF-36, and 
HADS sub-domains
Males (n = 77) Females (n = 65) p-value
NCSI (total score range) n = 77 n = 65
General Quality of Life (1–101.6) 15.0 (7.5–25.6) 15.4 (5.0–24.9) .336
Health-related Quality of Life 
(2–10)
4.0 (3.0–6.0) 4.0 (2.0–6.0) .821
Satisfaction Relationships (2–10) 3.0 (2.0–5.0) 3.0 (2.0–5.0) .350
Subjective Impairments (4–28) 10.1 ± 6.0 11.3 ± 6.1 .246
Behavioral Impairments (0–135.5) 0.0 (0.0–11.1) 8.8 (0.0–19.3) .013
Subjective Symptoms (2–20) 8.6 ± 5.2 9.3 ± 4.7 .246
Emotions about Symptoms (6–24) 9.0 (7.0–12.0) 9.0 (8.0–12.0) .566
Fatigue Symptoms (8–56) 33.9 ± 13.0 35.7 ± 13.6 .438
SF−36 n = 40 n = 36
Physical Functioning 90.0 (70.0–95.0) 75.0 (55.0–83.8) .005
Role Physical 87.5 (25.0–100.0) 75.0 (0.0–100.0) .331
Bodily Pain 90.0 (67.5–100.0) 68.8 (60.0–97.5) .268
General Health 54.5 ± 18.8 49.4 ± 24.3 .312
Vitality 58.3 ± 20.4 57.8 ± 21.3 .922
Social Functioning 90 (67.5–100.0) 68.8 (60.0–97.5) .268
Role Emotional 100.0 (75.0–100.0) 100.0 (66.7–100.0) .898
Mental health 74.0 ± 18.2 73.6 ± 18.3 .916
PCS 49.3 [42.3–54.6] 41.6 [35.5–53.1] .035
MCS 50.5 (44.4–55.5) 52.4 [44.5–56.2] .411
HADS n = 64 n = 49
Anxiety score 5.0 (2.3–8.0) 6.0 (2.0–9.0) .623
Depression score 4.0 (2.0–7.0) 3.0 (1.0–6.0) .251
Total score 9.5 (5.0–15.0) 9.0 (4.5–15.0) .814
Note: Data are expressed as M ± SD when parametrically distributed or as medians (IQR) when 
non-parametrically distributed. Every NCSI sub-domain has its own specific score range, displayed 
as: sub-domain (total score range).
Abbreviations: NCSI, Nijmegen Clinical Screening Instrument; SF-36, Short Form 36; HADS, 
Hospital Anxiety and Depression Scale; PCS, Physical Component Summary; MCS, Mental 
Component Summary.
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TA B L E  4   Comparison of NCSI, SF-36, and HADS sub-domain scores in HTAD participants with and without disease acceptance/true 
disease acceptance
Acceptance (n = 61) No acceptance (n = 81) p-value
NCSI n = 61 n = 81
General Quality of Life (1–101.6) 9.4 (4.0–15.2) 20.7 (11.5–37.1) ˂.001
Health-Related Quality of Life (2–10) 3.0 (2.0–4.0) 5.0 (4.0–7.0) ˂.001
Satisfaction Relationships (2–10) 3.0 (2.0–3.5) 4.0 (2.0–5.0) .147
Subjective Impairments (4–28) 7.0 (4.0–10.0) 12.0 (8.0–17.0) ˂.001
Behavioral Impairments (0–135.5) 0.0 (0.0–7.0) 9.8 (0.0–19.9) ˂.001
Subjective Symptoms (2–20) 6.5 (3.0–12.0) 10.00 (6.00–14.00) .001
Emotions about Symptoms (6–24) 8.00 (7.0–10.3) 10.00 (8.00–13.00) .005
Fatigue symptoms (8–56) 29.0 (12.4) 39.1 (12.3) ˂.001
SF−36 n = 35 n = 41
Physical Functioning 85.0 (75.0–95.0) 75.0 (57.5–90.0) .068
Role Physical 100.0 (75.0–100.0) 50.0 (0.0–100.0) .002
Bodily Pain 89.8 (67.4–100.0) 67.4 (44.9–89.8) .010
General Health 54.3 (12.7) 52.7 (12.7) ˂.001
Vitality 70.7 (15.5) 52.2 (19.2) ˂.001
Social Functioning 100.0 (87.5–100.0) 75.0 (62.5–87.5) ˂.001
Role Emotional 100.0 (100.0–100.0) 100.0 (33.3–100.0) .016
Mental health 60.0 (56.0–64.0) 56.0 (52.0–60.0) .153
HADS n = 46 n = 67
Anxiety score 4.0 (3.3) 7.1 (4.4) ˂.001
Depression score 2.8 (2.5) 6.1 (4.8) ˂.001
Total score 6.8 (5.1) 13.3 (8.3) ˂.001
True acceptance (n = 38) No true acceptance (n = 104) p-value
NCSI n = 38 n = 104
General Quality of Life (1–101.6) 6.0 (3.0–14.6) 17.7 (8.1–31.0) ˂.001
Health-related Quality of Life (2–10) 3.0 (2.00–4.3) 5.0 (3.0–7.0) ˂.001
Satisfaction Relationships (2–10) 3.0 (2.0–4.0) 3.0 (2.0–5.0) .322
Subjective Impairments (4–28) 7.0 (5.5–10.0) 10.5 (6.0–16.0) .003
Behavioral Impairments (0–135.5) 0.0 (0.0–8.5) 5.4 (0.0–18.2) .010
Subjective Symptoms (2–20) 5.0 (3.0–12.3) 10.0 (6.0–14.0) .006
Emotions about Symptoms (6–24) 8.0 (6.8–9.3) 10.0 (8.0–13.0) .008
Fatigue Symptoms (8–56) 29.6 (12.3) 36.6 (13.2) .005
SF−36 n = 24 n = 52
Physical Functioning 80.0 (71.3–93.8) 80.0 (60.0–93.8) .500
Role Physical 87.5 (56.3–100.0) 75.0 (0.0–100.0) .247
Bodily Pain 89.8 (67.4–97.5) 77.6 (57.1–100.0) .409
General Health 55.0 (12.9) 52.7 (12.5) .462
Vitality 70.4 (15.0) 56.3 (20.3) .003
Social Functioning 100.0 (87.5–100.0) 75.0 (62.5–100.0) .00
Role Emotional 100.0 (100.0–100.0) 100.0 (33.3–100.0) .131
Mental health 60.0 (56.0–64.0) 60.0 (52.0–60.0) .154
HADS n = 28 n = 85
Anxiety score 4.32 (3.44) 6.39 (4.37) .025
Depression score 2.64 (2.11) 5.45 (4.61) ˂.001
Total score 6.96 (4.69) 11.84 (8.31) ˂.001
Note: Data are expressed as mean with SD when parametrically distributed or as medians (IQR) when non-parametrically distributed.
Abbreviations: HTAD, hereditary thoracic aortic diseases; NCSI, Nijmegen Clinical Screening Instrument; SF-36, Short Form 36; HADS, Hospital 
Anxiety and Depression Scale.
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and previous aortic dissection showed almost no association with 
HRQOL. These finding are very similar to the findings of the largest 
HRQOL in HTAD patients performed so far by Goldfinger et al. (2017) 
and Moon et al. (2016). Similar findings were also reported in a very 
recent study in children and adolescents with MFS (Handisides 
et al., 2019). No explanation could be found from the differences in 
baseline variables between HTAD patients of working age with and 
without employment. Nonetheless, employment is influenced by 
many factors: disease-related factors, daily life aspects (also bio-be-
havioral factors), and demographic factors. In turn, employment has 
consequences on many factors as well, mainly social support and 
daily life aspects (independence, self-worth, family life, and social life). 
The connection between employment and all these different factors 
might explain its strong association with HRQOL and makes it an im-
portant factor to consider when counseling HTAD patients.
Even though no association between previous aortic dissection and 
HRQOL scores on the NCSI could be found, patients with previous aortic 
dissection scored lower on most SF-36 sub-domains. This was especially 
prominent in the PCS. Patients who previously underwent aortic surgery 
showed significantly lower scores on the sub-domain Physical Functioning, 
but overall seemed to show less prominent reduction in HRQOL. When 
interpreting these findings, it is important to keep in mind that the SF-36 
was only completed by a subset of our cohort (n = 76), which could explain 
why no statistically significant difference was detected.
4.1 | Clinical implications
The findings of this study should lead to more awareness among pa-
tients, families, and healthcare providers such as clinical geneticists, 
genetic counselors, cardiologists, and psychologists about the impact 
aortic disease has on the patients' HRQOL. In genetic counseling as 
well as cardiovascular treatment of HTAD patients, HRQOL assess-
ment should be incorporated, since this is crucial in order to provide 
the counseling and guidance needed for HTAD patients and their 
families. Additionally, we identified several factors which influence 
HRQOL in HTAD patients, which are valuable leads for counseling. We 
found that disease-related factors appear less important for HRQOL 
in HTAD patients than daily life aspects and coping style, which seems 
to positively influence HRQOL, and patients’ adherence to medical 
treatment. It has been mentioned before that subjective perception of 
the diagnosis may be an important factor influencing HRQOL (Velvin, 
Wilhelmsen, Johansen, Bathen, & Geirdal, 2019). Therefore, interven-
tions aimed at modifying coping strategy and other daily life aspects 
should be considered. The first step toward this can be made by incor-
porating patient-reported quality of life into clinical practice, in order 
to select the patients who need extra counseling and guidance.
4.2 | Limitations
This study has some limitations. Most importantly, the SF-36 and 
HADS questionnaires were not completed by all participants. This 
was due to logistic issues, because of which the SF-36 and HADS 
questionnaires could not be distributed during a certain period of 
time. Therefore, we do expect the distribution of the completed 
SF-36 and HADS questionnaires over our study population to be 
random. No significant difference was found between the percent-
age of males and females who completed the SF-36 and HADS 
questionnaires. Patients who completed the SF-36 had significantly 
larger aortic root diameters than those who did not. However, no 
associations were found between aortic root diameter and HRQOL. 
Furthermore, no significant difference in scores on any of the NCSI 
questionnaire sub-domains was found between patients who did, 
and those who did not complete the SF-36 questionnaire. There 
was no difference in HRQOL measurements between those two 
groups, since the NCSI sub-domains were found to correlate well 
with the SF-36 sub-domains (van Loenhout et al., 2013). It seems 
therefore that the subset of HTAD patients who completed the 
SF-36 and HADS questionnaires was representative of our total 
study population. Unfortunately, with the NCSI no comparison with 
the general population could be made. Therefore, our comparison 
between HTAD patients and the general Dutch population is lim-
ited. Furthermore, the response rate to the questionnaires was 
47.1%, which is comparable to other online surveys (Ebert, Huibers, 
Christensen, & Christensen, 2018). Finally, our study population 
contained many patients diagnosed with MFS (n = 123). However, 
baseline characteristics for patients with and without MFS seemed 
comparable (Supporting Information S2). Therefore, all participants 
were included in analysis comparing HTAD patients to the general 
population and comparing males and females. For studying associa-
tions between HRQOL and baseline characteristics only the patients 
with MFS were included.
5  | CONCLUSIONS
HTAD patients showed subnormal HRQOL. Females reported mark-
edly lower HRQOL compared to males and females in the general 
population, predominantly on physical well-being. Disease accept-
ance was associated with better HRQOL and patients’ adherence to 
treatment. Interestingly, factors such as employment, coping style, 
and disease acceptance seem more important for HRQOL than dis-
ease-related factors. These findings offer valuable leads for coun-
seling and guidance of both male and female HTAD patients.
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